Skip to main content
. 2016 Oct 21;7(47):77087–77095. doi: 10.18632/oncotarget.12800

Figure 3. Propofol decreases and etomidate increases the migration ability of CRC cells.

Figure 3

(A) Representative figures and data of transwell assay for SW480 and HCT116 cells treated with 100 μg/ml of dexmedetomidine in combination with 2 or 4 μg/ml of propofol for 24 h. (B) Representative figures and data of transwell assay for SW480 and HCT116 cells treated with 100 μg/ml of dexmedetomidine in combined with 2 or 4 μg/ml of etomidate for 24 h. Each bar represented the mean ± SD. The results were reproduced in three independent experiments. The asterisk (*) indicates P < 0.05. The asterisk (**) indicates P < 0.01.